In general, decreased Emerin expression during malignant transformation is associated with the nuclear structural defects required for the increased migratory and invasive capacities of cancer cells, leading to increased metastatic potential and unfavorable prognosis15,40,41. This evidence concerns the gene EMD and cancer.